Oxybutynin Chloride Extended-Release Tablet USP, 15 mg, 100 count bottles, Rx Only, Manufactured ...

FDA Drug Recall #D-0098-2024 — Class II — October 19, 2023

Recall Summary

Recall Number D-0098-2024
Classification Class II — Moderate risk
Date Initiated October 19, 2023
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Zydus Pharmaceuticals (USA) Inc
Location Pennington, NJ
Product Type Drugs

Product Description

Oxybutynin Chloride Extended-Release Tablet USP, 15 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Baddi, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. NDC # 68382-257-01.

Reason for Recall

Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.

Distribution Pattern

Nationwide.

Lot / Code Information

M211541, exp. date 10/2024 M211542, exp. date 10/2024 M212746, exp. date 10/2024 M300660, exp. date 12/2024

Other Recalls from Zydus Pharmaceuticals (USA) Inc

Recall # Classification Product Date
D-0544-2026 Class II Erythromycin Tablets, USP, 250 mg, 30 tablets p... Apr 29, 2026
D-0545-2026 Class II Erythromycin Tablets, USP, 500 mg, 30 tablets p... Apr 29, 2026
D-0400-2026 Class II Icosapent Ethyl Capsules, 1 gram, 120 Capsules ... Mar 9, 2026
D-0295-2026 Class II Icosapent Ethyl capsules, 1 gram, 120-count bot... Dec 30, 2025
D-0247-2026 Class III traZODONE Hydrochloride Tablets, USP, 100mg, 1,... Dec 19, 2025

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.